Medicare Enrolled
Dr. Andrew Pienkny, MD
Urology Physician · Berkeley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pienkny from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pienkny?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pienkny
Dr. Andrew Pienkny is an urology physician in Berkeley, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pienkny performed 2,762 Medicare services across 2,057 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pienkny received a total of $11,191 from 48 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pienkny is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 30% volume in CA
$11,191 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,762
Medicare services
Top 30% in CA for urology physician
2,057
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~145 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
763 | $106 | $305 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
375 | $4 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $76 | $216 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
264 | $10 | $28 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
243 | $11 | $33 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
80 | $68 | $195 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $135 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $135 | $391 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
72 | $0 | $1 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
71 | $50 | $137 |
| Simple change of bladder tube | 56 | $93 | $243 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
50 | $237 | $635 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
50 | $45 | $121 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
45 | $14 | $36 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
26 | $35 | $86 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
22 | $365 | $970 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $150 | $426 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
20 | $31 | $157 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
20 | $203 | $526 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
18 | $144 | $369 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
17 | $58 | $158 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
14 | $53 | $200 |
| New patient office visit, complex (60-74 min) | 11 | $187 | $516 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
11 | $105 | $229 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,191
Total received (2018-2024)
Avg $1,599/year across 7 years
Top 18% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,494 (58.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,685 (41.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$742
2023
$1,676
2022
$1,148
2021
$716
2020
$581
2019
$1,043
2018
$5,285
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$206
Astellas Pharma US Inc
$140
UROGEN PHARMA, INC.
$60
ACCORD HEALTHCARE, INC.
$49
PFIZER INC.
$48
180 Medical, Inc.
$30
Myriad Genetic Laboratories, Inc.
$30
Photocure Inc
$27
C. R. Bard, Inc. & Subsidiaries
$27
Telix Pharmaceuticals
$26
Verity Pharmaceuticals Inc.
$23
Janssen Biotech, Inc.
$22
Endo USA, Inc.
$20
Boston Scientific Corporation
$17
Sumitomo Pharma America, Inc.
$17
Top 3 companies account for 54.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$4,495
Bayer Healthcare Pharmaceuticals Inc.
$958
Janssen Biotech, Inc.
$709
Lutonix, Inc.
$550
NeoTract Inc.
$460
Amgen Inc.
$430
PFIZER INC.
$360
ABBVIE INC.
$327
Endo Pharmaceuticals Inc.
$279
AbbVie, Inc.
$272
Blue Earth Diagnostics Limited
$230
Dendreon Pharmaceuticals LLC
$207
Boston Scientific Corporation
$153
AbbVie Inc.
$139
Myovant Sciences Inc.
$121
TOLMAR Pharmaceuticals, Inc.
$114
Allergan Inc.
$113
Sumitomo Pharma America, Inc.
$94
Bayer HealthCare Pharmaceuticals Inc.
$94
Myriad Genetic Laboratories, Inc.
$80
PROCEPT BioRobotics Corporation
$72
UROVANT SCIENCES INC
$62
Ferring Pharmaceuticals Inc.
$60
UROGEN PHARMA, INC.
$60
Accord Healthcare, Inc.
$58
180 Medical, Inc.
$55
C. R. Bard, Inc. & Subsidiaries
$55
Olympus America Inc.
$53
Avadel Specialty Pharmaceuticals, LLC
$49
ACCORD HEALTHCARE, INC.
$49
PRN Medical Services, LLC
$48
Teleflex LLC
$44
KARL STORZ Endoscopy-America
$37
Merck Sharp & Dohme LLC
$31
Photocure Inc
$27
Telix Pharmaceuticals
$26
UroGen Pharma, Inc.
$25
Verity Pharmaceuticals Inc.
$23
Progenics Pharmaceuticals, Inc.
$23
Hollister Incorporated
$21
Endo USA, Inc.
$20
CONMED Corporation
$19
Coloplast Corp
$19
NxThera, Inc.
$16
COLOPLAST CORP
$15
Allergan, Inc.
$14
Acerus Pharmaceuticals Corporation
$13
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 55.1% of all-time payments
Associated products mentioned in payments ›
AVEED · AirSeal · Androgel · AquaBeam Robotic System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · CYSVIEW · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · GEMTESA · GENERAL - BPH · GENERAL BPH · GREENLIGHT · GreenLight XPS · ILLUCCIX · Infyna Chic · JELMYTO · KEYTRUDA · LUPRON DEPOT · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Laser Devices · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · Rezum · SPACEOAR · Titan · Trelstar · UroLift · UroLift System · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
149
Per 100K population
9.0
County median income
$126,240
Nearest hospital
ALTA BATES SUMMIT MEDICAL CENTER - ALTA BATES CAMP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pienkny is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pienkny experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pienkny performed 763 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pienkny receive payments from pharmaceutical companies?
Yes. Dr. Pienkny received a total of $11,191 from 48 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pienkny's costs compare to other urology physicians in Berkeley?
Dr. Pienkny's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pienkny) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Berkeley
Browse urology physicians in Berkeley ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology